Literature DB >> 25721078

Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

C S Schouten1, P de Graaf2, E Bloemena3, B I Witte4, B J M Braakhuis1, R H Brakenhoff1, C R Leemans1, J A Castelijns2, R de Bree5.   

Abstract

BACKGROUND AND
PURPOSE: Patients with human papillomavirus-positive oropharyngeal squamous cell carcinomas have a better survival rate than those with human papillomavirus-negative oropharyngeal squamous cell carcinomas. DWI characterizes biologically relevant tumor features, and the generated ADC may also provide prognostic information. We explored whether human papillomavirus status and ADC values are independent tumor characteristics.
MATERIALS AND METHODS: Forty-four patients with oropharyngeal squamous cell carcinomas underwent pretreatment DWI. ADC values for the primary tumors were determined by using 3 b-values in an ROI containing the largest area of solid tumor on a single section of an axial DWI image. Human papillomavirus status was determined with p16 immunostaining, followed by high-risk human papillomavirus DNA detection on the p16-positive cases.
RESULTS: Twenty-two patients were human papillomavirus-positive (50.0%). ADC values were not significantly different between human papillomavirus-negative (ADC(mean) = 1.56 [1.18-2.18] × 10(3) mm(2)/s) and human papillomavirus-positive tumors (ADC(mean) = 1.46 [1.07-2.16] × 10(3) mm(2)/s).
CONCLUSIONS: No significant association between ADC and human papillomavirus status was found in oropharyngeal squamous cell carcinomas. In our study population, differences in genetic and histologic features between human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas did not translate into different ADC values. Long-term follow-up studies are needed to establish whether ADC has prognostic value and whether this is independent of the human papillomavirus status.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 25721078      PMCID: PMC7964304          DOI: 10.3174/ajnr.A4271

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma.

Authors:  Rebecca D Chernock; James S Lewis; Qin Zhang; Samir K El-Mofty
Journal:  Hum Pathol       Date:  2010-03-17       Impact factor: 3.466

Review 2.  Basaloid squamous cell carcinoma of the head and neck: role of HPV and implication in treatment and prognosis.

Authors:  J Thariat; C Badoual; C Faure; C Butori; P Y Marcy; C A Righini
Journal:  J Clin Pathol       Date:  2010-10       Impact factor: 3.411

3.  Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Authors:  S Kim; L A Loevner; H Quon; A Kilger; E Sherman; G Weinstein; A Chalian; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-01       Impact factor: 3.825

4.  Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.

Authors:  Ashok Srinivasan; Thomas L Chenevert; Ben A Dwamena; Avraham Eisbruch; Kuanwong Watcharotone; James D Myles; Suresh K Mukherji
Journal:  J Comput Assist Tomogr       Date:  2012 Jan-Feb       Impact factor: 1.826

5.  Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma.

Authors:  Mitsuhiko Nakahira; Naoko Saito; Hiroshi Yamaguchi; Kiyomi Kuba; Masashi Sugasawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-24       Impact factor: 2.503

Review 6.  The molecular biology of head and neck cancer.

Authors:  C René Leemans; Boudewijn J M Braakhuis; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

7.  Histopathologic findings of HPV and p16 positive HNSCC.

Authors:  Abie H Mendelsohn; Chi K Lai; I Peter Shintaku; David A Elashoff; Steven M Dubinett; Elliot Abemayor; Maie A St John
Journal:  Laryngoscope       Date:  2010-09       Impact factor: 3.325

8.  Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.

Authors:  Sungheon Kim; Laurie Loevner; Harry Quon; Eric Sherman; Gregory Weinstein; Alex Kilger; Harish Poptani
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

9.  Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

Authors:  Pernille Lassen; Jesper G Eriksen; Stephen Hamilton-Dutoit; Trine Tramm; Jan Alsner; Jens Overgaard
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

10.  Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer.

Authors:  Misa Sumi; Noriyuki Sakihama; Tadateru Sumi; Minoru Morikawa; Masataka Uetani; Hiroyuki Kabasawa; Koichiro Shigeno; Kuniaki Hayashi; Haruo Takahashi; Takashi Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

View more
  8 in total

1.  Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology.

Authors:  T de Perrot; V Lenoir; M Domingo Ayllón; N Dulguerov; M Pusztaszeri; M Becker
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

2.  Discrimination of HPV status using CT texture analysis: tumour heterogeneity in oropharyngeal squamous cell carcinomas.

Authors:  Ji Young Lee; Miran Han; Kap Seon Kim; Su-Jin Shin; Jin Wook Choi; Eun Ju Ha
Journal:  Neuroradiology       Date:  2019-10-22       Impact factor: 2.804

3.  Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.

Authors:  Seyedmehdi Payabvash; Aimee Chan; Pejman Jabehdar Maralani; Ajay Malhotra
Journal:  Neuroradiol J       Date:  2019-05-14

Review 4.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

5.  Diffusion-Weighted Imaging to Assess HPV-Positive versus HPV-Negative Oropharyngeal Squamous Cell Carcinoma: The Importance of b-Values.

Authors:  V Lenoir; B M A Delattre; Y M'RaD; C De Vito; T de Perrot; M Becker
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

6.  Comparison of Imaging Findings between Human Papillomavirus-positive and -Negative Squamous Cell Carcinomas of the Maxillary Sinus.

Authors:  Masaya Kawaguchi; Hiroki Kato; Hiroyuki Tomita; Akira Hara; Natsuko Suzui; Tatsuhiko Miyazaki; Masayuki Matsuo
Journal:  J Clin Imaging Sci       Date:  2020-10-01

7.  Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation.

Authors:  M Ravanelli; A Grammatica; M Maddalo; M Ramanzin; G M Agazzi; E Tononcelli; S Battocchio; P Bossi; M Vezzoli; R Maroldi; D Farina
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

8.  Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation.

Authors:  Roland M Martens; Thomas Koopman; Cristina Lavini; Meedie Ali; Carel F W Peeters; Daniel P Noij; Gerben Zwezerijnen; J Tim Marcus; Marije R Vergeer; C René Leemans; Remco de Bree; Pim de Graaf; Ronald Boellaard; Jonas A Castelijns
Journal:  Eur Radiol       Date:  2020-08-26       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.